New Born Solutions
Kriba is a medical device startup focused on accelerating the screening, diagnosis, and monitoring of infections in serous body fluids through non-invasive technology. Leveraging AI-powered early detection solutions, Kriba aims to provide fast, empathetic, accessible, and efficient screening. Their technology offers early detection for agile and swift screening of infections, is non-invasive and provides a better service for patients, and is designed to be affordable and accessible globally. Kriba has received recognition such as the 'Most disruptive and scalable start-up award' at the 13th MIT Entrepreneurship Forum Spain and has been featured in press like El País and New Medical Economics. The company's core product is a non-invasive white blood cell counter in serous liquids, with applications in areas of care such as newborns, kidney, and eye care.
New Born Solutions
Kriba is a medical device startup focused on accelerating the screening, diagnosis, and monitoring of infections in serous body fluids through non-invasive technology. Leveraging AI-powered early detection solutions, Kriba aims to provide fast, empathetic, accessible, and efficient screening. Their technology offers early detection for agile and swift screening of infections, is non-invasive and provides a better service for patients, and is designed to be affordable and accessible globally. Kriba has received recognition such as the 'Most disruptive and scalable start-up award' at the 13th MIT Entrepreneurship Forum Spain and has been featured in press like El País and New Medical Economics. The company's core product is a non-invasive white blood cell counter in serous liquids, with applications in areas of care such as newborns, kidney, and eye care.